TOCQUEVILLE ASSET MANAGEMENT L.P. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$11,739,467
+1.5%
115,251
+0.6%
0.22%
+7.7%
Q2 2023$11,565,396
-29.5%
114,611
-35.7%
0.21%
-33.2%
Q1 2023$16,396,608
-0.3%
178,224
-1.7%
0.31%
-0.6%
Q4 2022$16,449,441
+19.3%
181,321
-0.0%
0.31%
+11.0%
Q3 2022$13,787,000
-11.7%
181,379
-1.8%
0.28%
-1.4%
Q2 2022$15,609,000
-3.8%
184,660
-0.1%
0.28%
+16.3%
Q1 2022$16,221,000
-3.9%
184,852
-4.2%
0.24%
+5.6%
Q4 2021$16,876,000
-17.5%
192,937
-22.9%
0.23%
-23.4%
Q3 2021$20,453,000
-11.0%
250,101
-0.7%
0.30%
-8.7%
Q2 2021$22,989,000
-9.7%
251,964
-15.4%
0.33%
-15.3%
Q1 2021$25,445,000
-12.3%
297,667
-3.1%
0.39%
-19.0%
Q4 2020$29,018,000
+6.4%
307,295
-2.1%
0.48%
-7.3%
Q3 2020$27,283,000
-2.4%
313,745
-2.0%
0.52%
-10.5%
Q2 2020$27,950,000
+20.0%
320,018
+13.3%
0.58%
+0.7%
Q1 2020$23,296,000
-12.9%
282,543
-0.0%
0.58%
+47.0%
Q4 2019$26,757,000
-13.0%
282,570
-20.2%
0.39%
-5.7%
Q3 2019$30,771,000
-11.9%
354,101
-7.4%
0.42%
-7.7%
Q2 2019$34,927,000
-10.1%
382,505
-5.4%
0.45%
-12.7%
Q1 2019$38,858,000
-3.5%
404,184
-13.8%
0.52%
-13.9%
Q4 2018$40,256,000
-12.4%
469,128
-12.0%
0.60%
+4.1%
Q3 2018$45,936,000
+15.6%
533,150
+1.4%
0.58%
+14.9%
Q2 2018$39,736,000
-3.7%
526,031
+3.1%
0.50%
-4.2%
Q1 2018$41,252,000
-12.6%
510,231
-9.2%
0.53%
-1.9%
Q4 2017$47,204,000
+3.5%
562,226
+5.8%
0.54%
+2.3%
Q3 2017$45,600,000
+10.1%
531,156
+7.1%
0.52%
+5.4%
Q2 2017$41,414,000
+25.5%
496,156
+11.7%
0.50%
+23.3%
Q1 2017$32,988,000
+12.1%
444,157
+9.9%
0.40%
+7.2%
Q4 2016$29,427,000
-9.5%
403,994
-1.8%
0.38%
-3.6%
Q3 2016$32,500,000
-48.7%
411,604
-46.4%
0.39%
-0.5%
Q2 2016$63,394,000
+149.5%
768,320
+119.1%
0.39%
+16.3%
Q1 2016$25,406,000
+13.1%
350,720
+34.3%
0.34%
+10.5%
Q4 2015$22,465,000
-4.8%
261,095
+1.7%
0.30%
-3.5%
Q3 2015$23,594,000
-8.0%
256,683
-1.6%
0.32%
+4.6%
Q2 2015$25,656,000
+4.4%
260,895
+4.7%
0.30%
+4.5%
Q1 2015$24,581,000
-20.7%
249,277
-25.5%
0.29%
-13.2%
Q4 2014$30,995,000
-15.3%
334,504
-14.0%
0.33%
-18.0%
Q3 2014$36,598,000
+3.7%
388,799
-0.2%
0.41%
+18.4%
Q2 2014$35,281,000
+12.0%
389,714
-5.1%
0.34%
-12.7%
Q3 2013$31,496,000
+7.8%
410,579
-0.6%
0.39%
-0.5%
Q2 2013$29,211,000413,1040.40%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders